Anti-cancer and anti-hepatitis C virus NS5B polymerase activity of etodolac 1,2,4-triazoles. (Record no. 24618162)

MARC details
000 -LEADER
fixed length control field 01731 a2200445 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517015240.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201605s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1475-6374
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.3109/14756366.2014.971780
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Çıkla-Süzgün, Pelin
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20160531
245 00 - TITLE STATEMENT
Title Anti-cancer and anti-hepatitis C virus NS5B polymerase activity of etodolac 1,2,4-triazoles.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of enzyme inhibition and medicinal chemistry
Date of publication, distribution, etc. 2015
300 ## - PHYSICAL DESCRIPTION
Extent 778-85 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision chemical synthesis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antiviral Agents
General subdivision chemical synthesis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Line, Tumor
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Proliferation
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dose-Response Relationship, Drug
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Screening Assays, Antitumor
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Enzyme Inhibitors
General subdivision chemical synthesis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Etodolac
General subdivision analogs & derivatives
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hepacivirus
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Molecular Structure
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Structure-Activity Relationship
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Triazoles
General subdivision chemical synthesis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Viral Nonstructural Proteins
General subdivision antagonists & inhibitors
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kaushik-Basu, Neerja
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Basu, Amartya
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Arora, Payal
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Talele, Tanaji T
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Durmaz, Irem
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Çetin-Atalay, Rengül
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Küçükgüzel, Ş Güniz
773 0# - HOST ITEM ENTRY
Title Journal of enzyme inhibition and medicinal chemistry
Related parts vol. 30
-- no. 5
-- p. 778-85
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.3109/14756366.2014.971780">https://doi.org/10.3109/14756366.2014.971780</a>
Public note Available from publisher's website

No items available.